仙琚制药：与爱施健公司签订阿更葡糖钠注射液中国境内推广服务商三方协议

Group 1 - The company has announced a partnership with Hangzhou Aomei Pharmaceutical Co., Ltd. to jointly authorize Aishijian (Guangdong) Pharmaceutical Co., Ltd. as the exclusive marketing service provider for Agomelatine injection in mainland China (excluding Hong Kong, Macau, and Taiwan) [1] - A milestone revenue-sharing agreement and sales revenue-sharing agreement have been signed, with both parties agreeing to share commercial revenue equally at 50% [1] - Additionally, a raw material procurement supply agreement and a supplementary contract for commissioned processing production have been established [1]